Oncology Pharma Stock Forecast

Buy candidate since Jul 09, 2026 Loss -2.14%

The Oncology Pharma stock price fell by -2.14% on the last day (Friday, 10th Jul 2026) from $0.0700 to $0.0685. During the last trading day the stock fluctuated 36.45% from a day low at $0.0502 to a day high of $0.0685. The price has been going up and down for this period, and there has been a -2.14% loss for the last 2 weeks. Volume has increased on the last day by 199 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 200 shares were bought and sold for approximately $13.70 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.52% during the next 3 months and, with a 90% probability hold a price between $0.0303 and $0.0646 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ONPH Signals & Forecast

The Oncology Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0570 and $0.0624. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -2.14%. Further fall is indicated until a new bottom pivot has been found. Oncology Pharma gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Oncology Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0616 and $0.0610. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oncology Pharma finds support just below today's level at $0.0616. If this is broken, then the next support from accumulated volume will be at $0.0610 and $0.0600.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0183 between high and low, or 36.45%. For the last week, the stock has had daily average volatility of 44.42%.

Our recommended stop-loss: $0.0660 (-3.63%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ONPH) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Oncology Pharma Inc. to open at $0.0624, and during the day (based on 14 day Average True Range), to move between $0.0586 and $0.0784, which gives a possible trading interval of +/-$0.0198 (+/-33.81%) up or down from last closing price. If Oncology Pharma Inc. takes out the full calculated possible swing range there will be an estimated 33.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0700 (2.19%) than the support at $0.0616 (10.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Oncology Pharma Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.303 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.0624 ( 8.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk